acut
lung
injuri
ali
syndrom
high
associ
mortal
character
sever
hypoxemia
pulmonari
infiltr
patient
critic
ill
conduct
first
investig
use
genom
wide
associ
gwa
approach
identifi
put
risk
variant
ali
genom
wide
genotyp
perform
use
illumina
human
quad
beadchip
perform
twostag
gwa
studi
follow
third
stage
function
character
discoveri
phase
phase
compar
european
american
traumaassoci
ali
case
european
american
populationbas
control
carri
forward
top
singl
nucleotid
polymorph
snp
replic
phase
phase
compris
nest
casecontrol
design
sampl
traumaassoci
ali
case
atrisk
trauma
nonali
control
ongo
cohort
studi
snp
replic
level
phase
subject
function
valid
phase
use
express
quantit
trait
loci
eqtl
analys
stimul
blymphoblastoid
cell
line
blcl
famili
trio
snp
discoveri
phase
replic
phase
includ
loci
prior
evid
role
ali
pathogenesi
function
evalu
replic
snp
reveal
exert
cisregulatori
effect
mrna
express
gene
p
encod
liprin
alpha
protein
involv
cell
adhes
integrin
express
cellmatrix
interact
studi
support
feasibl
futur
multicent
gwa
investig
ali
risk
identifi
potenti
function
candid
ali
risk
gene
futur
research
acut
lung
injuri
ali
syndrom
character
diffus
pulmonari
edema
sever
hypoxemia
absenc
clinic
evid
left
atrial
hypertens
ali
affect
estim
peopl
annual
unit
state
carri
mortal
proport
patient
expos
predispos
condit
develop
ali
eg
follow
sepsi
pneumonia
aspir
trauma
hypothes
individu
genet
variat
may
contribut
observ
variabl
ali
suscept
prior
studi
genet
ali
use
candid
gene
approach
identifi
variat
gene
control
inflamm
apoptosi
oxid
stress
endotheli
permeabl
among
other
may
confer
differenti
risk
develop
ali
ad
evid
risk
develop
ali
may
genet
basi
genomewid
associ
studi
gwa
power
unbias
tool
identif
common
genet
variant
eg
singl
nucleotid
polymorph
snp
associ
complex
trait
despit
potenti
limit
gwa
led
identif
genet
suscept
loci
reproduc
confer
risk
complex
diseas
crohn
diseas
rheumatoid
arthriti
type
ii
diabet
date
gwa
approach
appli
studi
ali
report
first
gwa
ali
suscept
use
three
stage
approach
includ
discoveri
phase
replic
phase
function
evalu
phase
use
gene
express
screen
famili
trio
hypothes
gwa
approach
would
identifi
common
genet
variant
associ
reproduc
differenti
risk
ali
studi
approv
institut
review
board
irb
children
hospit
philadelphia
chop
univers
pennsylvania
school
medicin
univers
washington
harvard
school
public
health
vanderbilt
univers
univers
california
san
francisco
chose
atrisk
trauma
popul
minim
heterogen
multipl
precipit
factor
ali
effici
allow
comparison
populationbas
control
major
trauma
larg
stochast
event
across
popul
ali
case
atrisk
control
identifi
sever
trauma
cohort
studi
perform
us
center
harvard
univers
massachusett
gener
hospit
univers
pennsylvania
vanderbilt
univers
univers
washington
univers
california
san
francisco
entri
criteria
injuri
sever
score
iss
admiss
emerg
depart
intens
care
unit
ali
defin
accord
american
european
consensu
confer
aecc
criteria
train
investig
site
written
inform
consent
obtain
particip
harvard
universitymassachusett
gener
hospit
vanderbilt
univers
univers
washington
univers
california
san
francisco
particip
univers
pennsylvania
collect
waiver
consent
grant
univers
pennsylvania
irb
populationbas
control
recruit
ongo
cohort
center
appli
genom
chop
perform
twostag
genotyp
strategi
third
stage
function
character
figur
discoveri
phase
phase
compar
european
american
traumaassoci
ali
case
european
american
populationbas
pediatr
healthi
control
taken
ongo
studi
children
hospit
philadelphia
chop
pediatr
popul
control
chosen
discoveri
phase
maxim
effici
cost
save
follow
reason
control
avail
larg
number
genotyp
genomewid
platform
similar
time
ali
chronic
diseas
known
effect
cumul
life
exposur
ali
risk
follow
trauma
major
environment
insult
trauma
requir
becom
risk
ali
recent
publish
studi
group
found
littl
differ
pediatr
popul
control
adult
control
carri
forward
snp
ali
associ
discoveri
sampl
replic
phase
phase
replic
popul
consist
nest
casecontrol
design
ali
case
atrisk
major
trauma
control
ongo
cohort
studi
five
particip
center
atrisk
control
defin
sever
injur
subject
admit
intens
care
unit
develop
ali
hospit
stay
primarili
drawn
two
site
hsph
uw
use
logist
regress
adjust
potenti
confound
clinic
factor
includ
age
iss
mechan
trauma
classifi
blunt
penetr
snp
achiev
signific
level
phase
replic
set
subject
function
evalu
use
express
quantit
trait
loci
eqtl
analys
cisregul
element
blcl
deriv
european
ancestri
yoruban
hapmap
trio
mother
father
offspr
evalu
two
condit
stimul
innat
immun
agonist
act
tolllik
receptor
cultur
media
alon
cisact
eqtl
set
blcl
determin
use
linear
regress
model
unrel
individu
cistest
perform
snp
allel
map
within
mb
array
probe
start
site
ci
eqtl
confirm
parentoffspr
trio
use
quantit
transmissiondisequilibrium
test
qtdt
implement
qtdt
softwar
packag
http
wwwsph
umicheducsgabecasisqtdtindexhtml
use
illumina
beadchip
illumina
san
diego
determin
genotyp
linkag
disequilibrium
bintag
polymorph
copi
number
variat
cnv
marker
approxim
ng
genom
dna
peripher
blood
sampl
use
subject
sampl
wholegenom
amplifi
fragment
precipit
resuspend
hybrid
buffer
denatur
sampl
next
hybrid
beadchip
hour
singl
base
extens
reaction
perform
chip
stain
imag
illumina
bead
array
reader
normal
intens
data
sampl
load
illumina
beadstudio
genotyp
call
use
manufactur
cluster
algorithm
gender
check
use
builtin
control
cluster
check
separ
deviat
hardyweinberg
lack
variat
monomorph
genotyp
deviat
hardyweinberg
equilibrium
demonstr
call
rate
minimum
qualiti
score
determin
manufactur
softwar
elig
statist
associ
analys
snp
imput
also
perform
discoveri
cohort
use
markov
chain
haplotyp
mach
softwar
http
wwwsph
umicheducsgabecasismachindexhtml
genotyp
imput
marker
present
genotyp
platform
use
softwar
version
use
studi
default
twostep
procedur
adopt
imput
softwar
requir
sever
input
file
snp
phase
haplotyp
use
hapmap
phase
haplotyp
releas
hapmap
utah
resid
ancestri
northern
western
europ
ceu
subject
download
hapmap
databas
http
wwwhapmaporg
analyz
mlinfo
file
gener
imput
process
use
recommend
r
threshold
flag
unreli
marker
use
imput
analysi
remov
marker
associ
test
also
analyz
mlqc
file
provid
pergenotyp
posterior
probabl
imput
call
use
threshold
flag
unreli
call
recod
nocal
genotyp
total
imput
autosom
marker
million
marker
phase
inform
hapmap
ceu
popul
pass
qualiti
control
ali
cohort
includ
loci
phase
supplement
tabl
statist
test
genet
associ
conduct
use
plink
reduc
risk
popul
stratif
due
misspecif
selfreport
ancestri
screen
case
control
ancestri
inform
marker
aim
use
structur
softwar
packag
remov
outlier
princip
compon
analysi
use
method
skol
assum
addit
model
twostag
design
case
control
carri
forward
snp
associ
addit
model
stage
replic
alpha
determin
would
greater
power
stage
replic
analys
detect
rel
risk
greater
allel
frequenc
greater
power
snp
detect
individu
phase
less
phase
case
control
yield
greater
power
detect
rel
risk
greater
alpha
allel
frequenc
greater
detect
rr
phase
power
detect
rel
risk
greater
alpha
allel
frequenc
greater
sampl
flow
ali
case
present
supplement
figur
characterist
ali
case
popul
control
atrisk
control
popul
contain
tabl
phase
mean
age
ali
case
year
male
blunt
trauma
mean
iss
mean
age
control
year
male
phase
age
gender
iss
mechan
trauma
similar
case
control
supplement
tabl
present
subject
characterist
site
age
gender
iss
similar
accord
individu
site
within
case
control
follow
qc
filter
genom
inflat
factor
phase
discoveri
set
indic
minim
differ
underli
popul
structur
case
control
figur
figur
repres
manhattan
plot
pvalu
phase
discoveri
cohort
total
genotyp
snp
demonstr
associ
phase
discoveri
cohort
snp
carri
forward
replic
phase
phase
supplement
tabl
present
result
imput
snp
phase
associ
ali
total
snp
achiev
phase
replic
set
similar
direct
adjust
age
gender
iss
mechan
trauma
supplement
tabl
note
sever
snp
gene
could
plausibl
associ
mechan
contribut
ali
tabl
includ
member
thrombospondin
tetraspanin
chitinas
famili
one
replic
variant
result
amino
acid
substitut
correspond
gene
product
substitut
snp
replic
phase
next
carri
forward
function
evalu
phase
eqtl
analys
stimul
hapmap
blcl
signific
differenti
express
mrna
p
accord
genotyp
cisact
snp
tabl
gene
encod
liprin
alpha
protein
involv
cell
adhes
cellmatrix
interact
addit
screen
discoveri
phase
test
associ
loci
prior
report
associ
ali
tabl
notabl
snp
promot
region
show
similar
effect
ali
risk
prior
report
howev
gwa
platform
specif
design
provid
adequ
coverag
loci
interest
mani
previous
associ
snp
gene
avail
therefor
also
report
result
snp
within
candid
gene
tabl
sever
candid
gene
contain
addit
loci
associ
ali
risk
includ
fa
mylk
although
specif
snp
prior
public
replic
case
fa
mylk
knowledg
first
genom
wide
associ
studi
examin
risk
ali
demonstr
associ
multipl
loci
two
independ
dataset
coupl
eqtl
analysi
put
function
result
priorit
novel
loci
futur
ali
research
furthermor
studi
provid
evid
feasibl
futur
gwa
trauma
atrisk
popul
includ
use
atrisk
control
discoveri
phase
put
function
genet
variant
identifi
studi
suggest
compel
hypothesi
explain
pathogenesi
observ
link
ali
risk
protein
encod
gene
member
liprin
lar
proteintyrosin
phosphataseinteract
protein
famili
liprin
mostli
studi
nervou
system
mammari
gland
develop
howev
liprin
alpha
bind
intracellular
membranedist
phosphatas
domain
tyrosin
phosphatas
leukocyt
antigen
relat
lar
may
regul
disassembl
focal
cell
adhes
influenc
cellmatrix
interact
liprin
alpha
recent
suggest
act
affect
local
integrin
integrin
involv
pathogenesi
ali
interact
extracellular
matrix
alter
cell
adhes
lung
vascular
permeabl
exact
function
genet
regul
gene
known
approxim
downstream
interven
gene
includ
futur
studi
may
focu
fine
map
region
better
understand
role
genet
regul
liprin
alpha
express
ali
risk
novel
featur
studi
use
eqtl
analys
employ
transform
stimul
lymphocyt
cell
line
evalu
function
differ
genotyp
list
provid
evid
differenti
express
accord
alirisk
genotyp
howev
futur
studi
may
demonstr
differenti
express
exist
cell
type
includ
approach
pneumocyt
macrophag
therefor
snp
found
differenti
express
function
phase
could
potenti
function
consequ
tissu
link
ali
risk
howev
time
public
avail
dataset
genomewid
genotyp
genomewid
gene
express
lung
specif
tissu
knowledg
present
result
associ
snp
replic
nomin
signific
pvalu
phase
lack
function
correl
studi
rule
role
ali
risk
replic
loci
sever
hypothes
put
role
ali
pathogenesi
present
tabl
particular
member
thrombospondin
chitinas
famili
implic
ali
pathogenesi
tetraspanin
shown
influenc
lipopolysaccharideinduc
macrophag
activ
lung
inflamm
recent
implic
regul
tissuehom
inflammatori
effect
tcell
includ
produc
cell
methionin
sulfoxid
reductas
msra
protect
oxid
stress
gene
encod
protein
signal
transduct
pathway
encod
rho
gtpase
activ
protein
rho
famili
gtpase
may
regul
endotheli
barrier
integr
interact
actin
cytoskeleton
likewis
protein
product
actinbind
lim
recent
describ
affect
barrier
integr
bronchial
epithelium
actin
bind
compon
junction
complex
one
replic
loci
result
amino
acid
chang
protein
product
encod
protein
also
known
involv
pulmonari
allerg
respons
evid
alter
level
due
genet
variat
human
likewis
potenti
function
consequ
specif
snp
set
promot
variant
prioriti
futur
studi
ali
note
origin
descript
gong
et
al
interact
detect
younger
age
seen
rel
young
age
trauma
studi
cohort
addit
although
prior
publish
snp
replic
genebas
replic
prior
fa
mylk
associ
ali
priorit
candid
loci
futur
studi
use
populationbas
control
deriv
stage
allow
optim
power
preserv
atrisk
trauma
control
replic
stage
although
approach
effici
econom
may
bias
introduc
control
suffer
predispos
risk
factor
major
trauma
drawn
pediatr
cohort
ali
develop
sever
precipit
insult
ali
suscept
gene
may
quiescent
unless
sever
environment
insult
occur
eg
sepsi
influenza
blood
transfus
major
trauma
therefor
possibl
ali
suscept
gene
appar
discoveri
phase
fals
neg
result
nonetheless
believ
choic
control
phase
would
lead
fals
posit
result
follow
reason
none
candid
gene
plausibl
link
surviv
age
traumat
insult
b
pediatr
popul
control
shown
similar
adult
popul
control
c
phase
use
atrisk
nest
control
major
trauma
follow
ali
determin
develop
syndrom
therebi
minim
select
bia
howev
like
larger
discoveri
phase
use
atrisk
trauma
control
similar
age
may
uncov
addit
risk
variant
estim
case
atrisk
control
would
provid
adequ
power
detect
genotyp
rel
risk
greater
common
variant
larger
sampl
would
need
uncommon
variant
studi
sever
addit
limit
first
discoveri
sampl
set
lower
bound
power
demonstr
gwa
signific
although
power
detect
common
snp
twostag
design
replic
sampl
modest
may
miss
import
less
common
variant
therefor
neg
find
interpret
caution
howev
threestag
genotyp
approach
function
character
result
associ
signal
minim
chanc
find
fals
posit
associ
likewis
effici
economi
discoveri
phase
use
alreadygenotyp
control
singl
site
therefor
confound
due
popul
stratif
may
possibl
howev
statist
approach
yield
excel
genom
inflat
factor
result
replic
subject
taken
sever
site
phase
make
popul
admixtur
unlik
bia
result
none
snp
achiev
signific
deriv
set
genomewid
multipl
comparison
level
howev
interpret
lack
evid
genet
basi
ali
given
modest
sampl
size
given
posit
result
threestag
studi
design
chose
trauma
popul
minim
heterogen
ali
etiolog
effici
leverag
populationbas
control
phase
discoveri
phase
howev
pathophysiolog
ali
follow
trauma
may
differ
risk
ali
popul
therefor
find
may
generaliz
caus
ali
futur
studi
need
replic
find
atrisk
popul
first
gwa
acut
lung
injuri
studi
uncov
import
novel
variant
regul
express
priorit
futur
studi
furthermor
studi
support
feasibl
use
multiplestag
gwa
approach
futur
studi
ali
risk
bench
translat
research
studi
focus
role
liprin
alpha
ali
pathogenesi
seem
warrant
addit
replic
candid
gene
prior
ali
associ
well
sever
gene
pathway
evid
role
ali
pathogenesi
serv
prioriti
candid
futur
studi
like
complex
syndrom
addit
novel
put
risk
gene
like
uncov
tabl
replic
snp
alter
express
stimul
blymphoblast
cell
line
blcl
tabl
ali
associ
previous
report
ali
candid
gene
snp
gene
level
discoveryphas
popul
figur
schemat
represent
qualiti
control
method
employ
total
case
ali
submit
analysi
exclud
analys
due
evid
noneuropean
ancestri
abbrevi
ali
acut
lung
injuri
aim
ancestri
inform
marker
pca
princip
compon
analysi
preqc
ea
prequal
control
ea
europeanamerican
gwa
genom
wide
associ
tif
na
ns
snplevel
result
provid
specif
locu
previous
report
associ
ali
either
directli
genotyp
human
platform
abl
imput
posterior
probabl
r
imput
possibl
due
snp
rariti
lack
linkag
disequilibrium
genotyp
marker
result
given
avail
na
gene
level
strongest
associ
report
gene
annot
ncbi
refseq
posit
report
associ
result
probabl
p
snp
annot
gene
associ
p
result
given
signific
ns
result
popul
previous
publish
tabl
cont
